Search Within

Isabelle C Riviere

Formats
  1. Meeting Abstract (139)
  2. Journal Article (93)
  3. Book Section (2)
  4. Conference Paper (2)
  5. Review (2)
  6. Editorial (1)
  7. Research Letter (1)
Groups
  1. Department of Medicine (240)
  2. Hematologic Malignancies, Division of (240)
  3. GSK Faculty (219)
  4. Center for Hematologic Malignancies (216)
  5. Hematologic Malignancies Research (213)
  6. Sloan Kettering Institute Faculty (207)

More Groups

People
  1. Michel Sadelain (200)
  2. Xiuyan Wang (112)
  3. Renier Brentjens (111)
  4. Jae Park (83)
  5. Brigitte Senechal (42)
  6. Kevin Curran (40)

More People

Years
  1. 2025 (2)
  2. 2023 (11)
  3. 2022 (13)
  4. 2021 (13)
  5. 2020 (8)
  6. 2019 (18)

More Years

Publications
  1. Blood (55)
  2. Molecular Therapy (42)
  3. Journal of Clinical Oncology (20)
  4. Human Gene Therapy (10)
  5. Cancer Research (8)
  6. Haematologica (6)

More Publications

Publishers
  1. Nature Publishing Group (67)
  2. American Society of Hematology (56)
  3. American Society of Clinical Oncology (21)
  4. American Association for Cancer Research (15)
  5. Elsevier Inc. (15)
  6. Mary Ann Liebert, Inc (10)

More Publishers

Results (240)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • In vivo anti-tumor activity of genetically modified T cells is dependent on the method of ex vivo T cell expansion
    Meeting Abstract

    Brentjens, R. J.; Latouche, J. B.; Riviere, I.; Sadelain, M.
    Blood (2002)

    Fulltext@MSK | Save
  • Cure of lethal beta(0)-thalassemia by lentivirus-mediated globin gene transfer in a novel murine disease model
    Meeting Abstract

    Rivella, S.; May, C.; Chadburn, A.; Riviere, I.; Sadelain, M.
    Blood (2002)

    Fulltext@MSK | Save
  • Sturm und drang over suicidal lymphocytes
    Journal Article

    Sadelain, M.; Rivière, I.
    Molecular Therapy (2002)

    Fulltext@MSK | Save
  • Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ/CD28 receptor
    Journal Article

    Maher, J.; Brentjens, R. J.; Gunset, G.; Rivière, I.; Sadelain, M.
    Nature Biotechnology (2002)

    Fulltext@MSK | Save
  • Phase I trial of human tyrosinase DNA vaccination in dogs with advanced malignant melanoma
    Meeting Abstract

    Bergman, P. J.; McKnight, J.; Novosad, A.; Chamey, S.; Farrelly, J.; Jeffers, Y.; Egan, M.; Craft, D.; Gallardo, H.; Riviere, I.; more...
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • Long term survival of SCID-beige mice bearing Raji cell tumors after intravenous treatment with human T cells genetically modified to recognize the CD19 antigen
    Meeting Abstract

    Brentjens, R. J.; Gong, M. C.; Latouche, J. B.; Riviere, I.; Sadelain, M.
    Blood (2001)

    Fulltext@MSK | Save
  • Noninvasive imaging of human radiolabeled antigen-specific donor T lymphocytes after adoptive immunotherapy in SCID mice
    Meeting Abstract

    Koehne, G.; Zanzonico, P.; Gallardo, H. F.; May, C.; Balatoni, J.; Riviere, I.; O'Reilly, R. J.; Sadelain, M.; Larson, S. M.
    Blood (2000)

    Fulltext@MSK | Save
  • Issues in the manufacture and transplantation of genetically modified hematopoietic stem cells
    Journal Article

    Sadelain, M.; Frassoni, F.; Rivière, I.
    Current Opinion in Hematology (2000)

    Fulltext@MSK | Save
  • Retroviral-mediated gene transfer in primary murine and human T-lymphocytes
    Journal Article

    Riviere, I.; Gallardo, H. F.; Hagani, A. B.; Sadelain, M.
    Applied Biochemistry and Biotechnology (2000)

    Fulltext@MSK | Save
  • Genetic treatment of severe hemoglobinopathies
    Journal Article

    Rivière, I.; Sadelain, M.
    Hématologie (1999)

    Fulltext@MSK | Save